Literature DB >> 9779518

Effect of NMDA lesion of the medial preoptic neurons on sleep and other functions.

J John1, V M Kumar.   

Abstract

This study was undertaken to determine the effects of the destruction of the medial preoptic area (mPOA) neurons by N-methyl D-aspartic acid (NMDA), on sleep-wakefulness (S-W), locomotor activity, body weight, rectal temperature, and food and water intake in rats. The NMDA lesion of the mPOA produced long-lasting insomnia with marked reduction in the deeper stages of sleep, including paradoxical sleep. The reduction in the duration of sleep episodes in the lesioned rats indicated their inability to maintain sleep. The insomnia resulting from a decreased sleep pressure did not alter the sleep-initiating ability. Though the day-night distribution of sleep remained largely unaffected, there was an increase in locomotor activity during the light period. There was no increase in food intake to compensate for the high energy expenditure resulting not only from hyperactivity but also from hyperthermia in the mPOA-lesioned rats. Thus, body weights of the rats were reduced even without any change in food and water intake. However, the changes in body temperature and locomotor activity after the mPOA neuronal loss may not have exerted a major influence on S-W, as the alterations in all these parameters had different time courses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779518     DOI: 10.1093/sleep/21.6.587

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  28 in total

1.  Sleep-waking discharge patterns of median preoptic nucleus neurons in rats.

Authors:  Natalia Suntsova; Ronald Szymusiak; Md Noor Alam; Ruben Guzman-Marin; Dennis McGinty
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

2.  Dynamics of neuron activity in the lateral preoptic area of the hypothalamus during the sleep-waking cycle.

Authors:  N V Suntsova; O Yu Dergacheva
Journal:  Neurosci Behav Physiol       Date:  2003-09

3.  The role of the medial preoptic area of the hypothalamus in organizing the paradoxical phase of sleep.

Authors:  N V Suntsova; O Yu Dergacheva
Journal:  Neurosci Behav Physiol       Date:  2004-01

4.  Alpha-1 adrenergic receptors in the medial preoptic area are involved in the induction of sleep.

Authors:  Velayudhan Mohan Kumar; Ramalingam Vetrivelan; Hruda Nanda Mallick
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

Review 5.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

6.  Neuronal activity in the preoptic hypothalamus during sleep deprivation and recovery sleep.

Authors:  Md Aftab Alam; Sunil Kumar; Dennis McGinty; Md Noor Alam; Ronald Szymusiak
Journal:  J Neurophysiol       Date:  2013-10-30       Impact factor: 2.714

7.  Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats.

Authors:  Joshi John; Lalini Ramanathan; Jerome M Siegel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

8.  c-Fos expression in neurons projecting from the preoptic and lateral hypothalamic areas to the ventrolateral periaqueductal gray in relation to sleep states.

Authors:  K-C Hsieh; I Gvilia; S Kumar; A Uschakov; D McGinty; M N Alam; R Szymusiak
Journal:  Neuroscience       Date:  2011-05-17       Impact factor: 3.590

Review 9.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

10.  Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep.

Authors:  J Lu; M A Greco; P Shiromani; C B Saper
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.